{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T08:52:08Z","timestamp":1792313528894,"version":"4.4.0"},"reference-count":264,"publisher":"Royal Society of Chemistry (RSC)","issue":"43","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":273,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100023673","name":"Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2501"],"award-info":[{"award-number":["IMSIU-DDRSP2501"]}],"id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rsc.org"],"crossmark-restriction":true},"short-container-title":["RSC Adv."],"abstract":"<jats:p>Medicinal chemistry perspective on anticancer drug design (2015\u20132025).<\/jats:p>","DOI":"10.1039\/d5ra05472a","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:10:34Z","timestamp":1759313434000},"page":"36441-36471","update-policy":"https:\/\/doi.org\/10.1039\/rsc_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Medicinal chemistry perspectives on anticancer drug design based on clinical applications (2015\u20132025)"],"prefix":"10.1039","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8173-6073","authenticated-orcid":false,"given":"Ahmed A.","family":"Al-Karmalawy","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, The University of Mashreq, Baghdad 10023, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Eissa","sequence":"additional","affiliation":[{"name":"College of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada A.","family":"Ashour","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura National University, Gamasa 7731168, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek A.","family":"Yousef","sequence":"additional","affiliation":[{"name":"College of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa Omar","family":"Al Khatib","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia S.","family":"Hawas","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"292","published-online":{"date-parts":[[2025]]},"reference":[{"key":"D5RA05472A\/cit1\/1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/biology12091183","volume":"12","author":"Ottaiano","year":"2023","journal-title":"Biology"},{"key":"D5RA05472A\/cit2\/1","first-page":"1340","volume":"6","author":"Alqaraleha","year":"2024","journal-title":"J. Med. Pharm. Chem. Res."},{"key":"D5RA05472A\/cit3\/1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/life12010048","volume":"12","author":"Basak","year":"2021","journal-title":"Life"},{"key":"D5RA05472A\/cit4\/1","doi-asserted-by":"crossref","first-page":"15330338241242635","DOI":"10.1177\/15330338241242635","volume":"23","author":"Al Taher","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"issue":"4","key":"D5RA05472A\/cit5\/1","first-page":"583","volume":"8","author":"Koper","year":"2023","journal-title":"Phys. Sci. Rev."},{"key":"D5RA05472A\/cit6\/1","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1080\/14756366.2022.2096019","volume":"37","author":"Belal","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"D5RA05472A\/cit7\/1","volume-title":"Chemotherapy Furthers Cancer by Killing T-Cells","author":"Cvrat","year":"2021","unstructured":"M.Cvrat  and  D. J. C.Sanat ,  Chemotherapy Furthers Cancer by Killing T-Cells ,  2021"},{"issue":"9","key":"D5RA05472A\/cit8\/1","first-page":"e69113","volume":"16","author":"Munir","year":"2024","journal-title":"Cureus"},{"key":"D5RA05472A\/cit9\/1","doi-asserted-by":"crossref","first-page":"105770","DOI":"10.1016\/j.bioorg.2022.105770","volume":"123","author":"El-Naggar","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"3","key":"D5RA05472A\/cit10\/1","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1039\/D4MD00750F","volume":"16","author":"Zeidan","year":"2025","journal-title":"RSC Med. Chem."},{"key":"D5RA05472A\/cit11\/1","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/cncr.34757","volume":"129","author":"Herrera-Ju\u00e1rez","year":"2023","journal-title":"Cancer"},{"key":"D5RA05472A\/cit12\/1","first-page":"29","author":"Barras","year":"2024","journal-title":"Molecules"},{"key":"D5RA05472A\/cit13\/1","doi-asserted-by":"crossref","first-page":"105995","DOI":"10.1016\/j.bioorg.2022.105995","volume":"127","author":"Hammouda","year":"2022","journal-title":"Bioorg. Chem."},{"key":"D5RA05472A\/cit14\/1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s10555-024-10188-5","volume":"43","author":"Ostios-Garcia","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"D5RA05472A\/cit15\/1","doi-asserted-by":"crossref","first-page":"859596","DOI":"10.3389\/fonc.2022.859596","volume":"12","author":"Jiao","year":"2022","journal-title":"Front. Oncol."},{"key":"D5RA05472A\/cit16\/1","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1039\/D4MD00585F","volume":"15","author":"Abdel-Motaal","year":"2024","journal-title":"RSC Med. Chem."},{"key":"D5RA05472A\/cit17\/1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41409-025-02523-3","volume":"60","author":"Koller","year":"2025","journal-title":"Bone Marrow Transplant."},{"key":"D5RA05472A\/cit18\/1","doi-asserted-by":"crossref","first-page":"11422","DOI":"10.1039\/D2NJ01646J","volume":"46","author":"Hammoud","year":"2022","journal-title":"New J. Chem."},{"key":"D5RA05472A\/cit19\/1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/or.2023.8612","volume":"50","author":"Alzahrani","year":"2023","journal-title":"Oncol. Rep."},{"issue":"9","key":"D5RA05472A\/cit20\/1","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.3390\/ijms24098457","volume":"24","author":"Jang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"D5RA05472A\/cit21\/1","doi-asserted-by":"crossref","first-page":"14946","DOI":"10.1039\/D5RA02179K","volume":"15","author":"Al-Karmalawy","year":"2025","journal-title":"RSC Adv."},{"key":"D5RA05472A\/cit22\/1","doi-asserted-by":"crossref","first-page":"107223","DOI":"10.1016\/j.bioorg.2024.107223","volume":"145","author":"Gaber","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"22","key":"D5RA05472A\/cit23\/1","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.3390\/cancers13225650","volume":"13","author":"Wordeman","year":"2021","journal-title":"Cancers"},{"key":"D5RA05472A\/cit24\/1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/life12010048","volume":"12","author":"Basak","year":"2021","journal-title":"Life"},{"key":"D5RA05472A\/cit25\/1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"D5RA05472A\/cit26\/1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/acs.jmedchem.2c01668","volume":"66","author":"Al-Karmalawy","year":"2023","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit27\/1","doi-asserted-by":"crossref","first-page":"106936","DOI":"10.1016\/j.bioorg.2023.106936","volume":"142","author":"Abbass","year":"2024","journal-title":"Bioorg. Chem."},{"key":"D5RA05472A\/cit28\/1","doi-asserted-by":"crossref","first-page":"e22228","DOI":"10.1002\/ddr.22228","volume":"85","author":"El-Gamil","year":"2024","journal-title":"Drug Dev. Res."},{"key":"D5RA05472A\/cit29\/1","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.3390\/molecules26216677","volume":"26","author":"Abourehab","year":"2021","journal-title":"Molecules"},{"key":"D5RA05472A\/cit30\/1","doi-asserted-by":"crossref","first-page":"1328424","DOI":"10.3389\/fchem.2023.1328424","volume":"11","author":"Al-Karmalawy","year":"2023","journal-title":"Front. Chem."},{"key":"D5RA05472A\/cit31\/1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/biology13100844","volume":"13","author":"Wesley","year":"2024","journal-title":"Biology"},{"key":"D5RA05472A\/cit32\/1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4155\/fmc-2023-0112","volume":"15","author":"El-Kalyoubi","year":"2023","journal-title":"Future Med. Chem."},{"key":"D5RA05472A\/cit33\/1","first-page":"51","volume-title":"Progress in Molecular Biology and Translational Science","volume":"197","author":"Acharjee","year":"2023","unstructured":"S.Acharjee ,  S.Chauhan ,  R.Pal  and  R. S.Tomar , in  Progress in Molecular Biology and Translational Science , ed.  V. Singh  and  I. Mani ,  Academic Press ,  2023 , vol.  197 ,  pp. 51\u201392"},{"key":"D5RA05472A\/cit34\/1","doi-asserted-by":"crossref","first-page":"14964","DOI":"10.3390\/ijms241914964","volume":"24","author":"Patnaik","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"D5RA05472A\/cit35\/1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","volume":"9","author":"Zhong","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"D5RA05472A\/cit36\/1","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.2147\/IJN.S448684","volume":"19","author":"Song","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"D5RA05472A\/cit37\/1","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1021\/acs.jmedchem.3c00449","volume":"66","author":"Dewey","year":"2023","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit38\/1","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1021\/acs.jmedchem.3c01521","volume":"66","author":"Yu","year":"2023","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit39\/1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/acs.bioconjchem.4c00254","volume":"35","author":"Hong","year":"2024","journal-title":"Bioconjugate Chem."},{"key":"D5RA05472A\/cit40\/1","doi-asserted-by":"crossref","first-page":"1951427","DOI":"10.1080\/19420862.2021.1951427","volume":"13","author":"Dean","year":"2021","journal-title":"mAbs"},{"key":"D5RA05472A\/cit41\/1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-023-00783-w","volume":"20","author":"Tarantino","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"D5RA05472A\/cit42\/1","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1021\/acs.chemrev.4c00469","volume":"125","author":"Raavi","year":"2025","journal-title":"Chem. Rev."},{"key":"D5RA05472A\/cit43\/1","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1021\/acs.jmedchem.4c02106","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit44\/1","doi-asserted-by":"crossref","first-page":"13121","DOI":"10.3390\/ijms252313121","volume":"25","author":"Wu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"D5RA05472A\/cit45\/1","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/molecules28041959","volume":"28","author":"Todorov","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"D5RA05472A\/cit46\/1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/inorganics12010029","volume":"12","author":"Kostova","year":"2024","journal-title":"Inorganics"},{"key":"D5RA05472A\/cit47\/1","doi-asserted-by":"crossref","first-page":"215579","DOI":"10.1016\/j.ccr.2023.215579","volume":"501","author":"Abdolmaleki","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"D5RA05472A\/cit48\/1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/acs.chemmater.2c03003","volume":"35","author":"Gao","year":"2023","journal-title":"Chem. Mater."},{"key":"D5RA05472A\/cit49\/1","doi-asserted-by":"crossref","first-page":"38778","DOI":"10.1039\/D4RA07316A","volume":"14","author":"Zakaria","year":"2024","journal-title":"RSC Adv."},{"key":"D5RA05472A\/cit50\/1","doi-asserted-by":"crossref","first-page":"102845","DOI":"10.1016\/j.jddst.2021.102845","volume":"66","author":"Mahmoud","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"6","key":"D5RA05472A\/cit51\/1","doi-asserted-by":"crossref","first-page":"e202104045","DOI":"10.1002\/slct.202104045","volume":"7","author":"Joy","year":"2022","journal-title":"ChemistrySelect"},{"key":"D5RA05472A\/cit52\/1","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.2147\/IJN.S421617","volume":"18","author":"Tafish","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"D5RA05472A\/cit53\/1","doi-asserted-by":"crossref","first-page":"2242714","DOI":"10.1080\/14756366.2023.2242714","volume":"38","author":"El-Kalyoubi","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"11","key":"D5RA05472A\/cit54\/1","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/pharmaceutics14112346","volume":"14","author":"Zhou","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"D5RA05472A\/cit55\/1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/pharmaceutics15020484","volume":"15","author":"Lou","year":"2023","journal-title":"Pharmaceutics"},{"key":"D5RA05472A\/cit56\/1","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1158\/1535-7163.MCT-09-0016","volume":"8","author":"Pfister","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"D5RA05472A\/cit57\/1","doi-asserted-by":"crossref","first-page":"115422","DOI":"10.1016\/j.ejmech.2023.115422","volume":"256","author":"Bhatia","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"D5RA05472A\/cit58\/1","doi-asserted-by":"crossref","first-page":"117429","DOI":"10.1016\/j.biopha.2024.117429","volume":"180","author":"El-Masry","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"D5RA05472A\/cit59\/1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12967-025-06457-8","volume":"23","author":"Zhuang","year":"2025","journal-title":"J. Transl. Med."},{"key":"D5RA05472A\/cit60\/1","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S1470-2045(24)00037-8","volume":"25","author":"Scott","year":"2024","journal-title":"Lancet Oncol."},{"issue":"10","key":"D5RA05472A\/cit61\/1","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.3390\/molecules27103062","volume":"27","author":"Holik","year":"2022","journal-title":"Molecules"},{"key":"D5RA05472A\/cit62\/1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/ph16020299","volume":"16","author":"Kumar","year":"2023","journal-title":"Pharmaceuticals"},{"key":"D5RA05472A\/cit63\/1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s10967-022-08624-3","volume":"332","author":"Roesch","year":"2023","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"D5RA05472A\/cit64\/1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","volume":"376","author":"Strosberg","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit65\/1","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2967\/jnumed.115.171397","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"key":"D5RA05472A\/cit66\/1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-031-23205-3","volume-title":"Molecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications","author":"Vallabhajosula","year":"2023","unstructured":"S.Vallabhajosula , in  Molecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications ,  Springer ,  2023 ,  pp. 1\u201319"},{"key":"D5RA05472A\/cit67\/1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/acs.bioconjchem.0c00015","volume":"31","author":"Jackson","year":"2020","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"D5RA05472A\/cit68\/1","first-page":"19","volume":"2","author":"Sreedevi","year":"2024","journal-title":"Int. J. Trends OncoScience"},{"key":"D5RA05472A\/cit69\/1","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202507.1404.v1","volume-title":"Preprints","author":"Salgueiro","year":"2025","unstructured":"M. J.Salgueiro  and  M.Zubillaga ,  Theranostic Nanoplatforms in Nuclear Medicine: Current Advances, Emerging Trends, and Perspectives for Personalized Oncology ,  Preprints ,  2025 , preprint,  10.20944\/preprints202507.1404.v1"},{"key":"D5RA05472A\/cit70\/1","first-page":"269","volume-title":"Computational Drug Discovery and Design","author":"Serghini","year":"2023","unstructured":"A.Serghini ,  S.Portelli  and  D. B.Ascher , in  Computational Drug Discovery and Design ,  Springer ,  2023 ,  pp. 269\u2013294"},{"key":"D5RA05472A\/cit71\/1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/9781394249190.ch9","volume-title":"Computational Methods for Rational Drug Design","author":"Chakraborty","year":"2025","unstructured":"S.Chakraborty ,  S.Chakraborty ,  B.Sarkar ,  R.Ghosh ,  S.Roy ,  N. K.Singh  and  G.Rakshit ,  Scaffold hopping and de novo drug design ,  Computational Methods for Rational Drug Design ,  2025 ,  pp. 195\u2013219"},{"key":"D5RA05472A\/cit72\/1","doi-asserted-by":"crossref","first-page":"e1568","DOI":"10.1002\/wcms.1568","volume":"12","author":"Staszak","year":"2022","journal-title":"WIREs Comput. Mol. Sci."},{"key":"D5RA05472A\/cit73\/1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"D5RA05472A\/cit74a\/1","volume-title":"Human-in-the-Loop Machine Learning: Active Learning and Annotation for Human-Centered AI","author":"Monarch","year":"2021","unstructured":"R. M.Monarch ,  Human-in-the-Loop Machine Learning: Active Learning and Annotation for Human-Centered AI ,  Simon and Schuster ,  2021"},{"key":"D5RA05472A\/cit74b\/1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/diagnostics15030397","volume":"15","author":"Azadinejad","year":"2025","journal-title":"Diagnostics"},{"key":"D5RA05472A\/cit75\/1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/diagnostics15030397","volume":"15","author":"Azadinejad","year":"2025","journal-title":"Diagnostics"},{"issue":"2","key":"D5RA05472A\/cit76\/1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/mtsp.mtsp_14_23","volume":"7","author":"Ashiwaju","year":"2023","journal-title":"Matrix Sci. Pharma"},{"key":"D5RA05472A\/cit77\/1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov."},{"key":"D5RA05472A\/cit78\/1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1612674","volume":"376","author":"Mok","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit79\/1","author":"FDA","unstructured":"FDA ,  FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-osimertinib-chemotherapy-egfr-mutated-non-small-cell-lung-cancer"},{"key":"D5RA05472A\/cit80\/1","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1021\/jm500973a","volume":"57","author":"Finlay","year":"2014","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit81\/1","doi-asserted-by":"crossref","first-page":"117796","DOI":"10.1016\/j.bmc.2024.117796","volume":"109","author":"Patil","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"D5RA05472A\/cit82\/1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(19)30735-1","volume":"21","author":"Rini","year":"2020","journal-title":"Lancet Oncol."},{"key":"D5RA05472A\/cit83\/1","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1093\/oncolo\/oyac255","volume":"28","author":"Meza","year":"2023","journal-title":"Oncologist"},{"key":"D5RA05472A\/cit84\/1","first-page":"e35675","volume":"15","author":"Sakellakis","year":"2023","journal-title":"Cureus"},{"key":"D5RA05472A\/cit85\/1","author":"FDA","unstructured":"FDA ,  FDA approves tivozanib for relapsed or refractory advanced renal cell carcinoma ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-tivozanib-relapsed-or-refractory-advanced-renal-cell-carcinoma"},{"issue":"1","key":"D5RA05472A\/cit86\/1","first-page":"43","volume":"31","author":"Yousefbeyk","year":"2024","journal-title":"Pharm. Sci."},{"key":"D5RA05472A\/cit87\/1","first-page":"1","author":"Lee","year":"2025","journal-title":"Drugs"},{"key":"D5RA05472A\/cit88\/1","author":"FDA","unstructured":"FDA ,  FDA approves vimseltinib for symptomatic tenosynovial giant cell tumor ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-vimseltinib-symptomatic-tenosynovial-giant-cell-tumor"},{"key":"D5RA05472A\/cit89\/1","doi-asserted-by":"crossref","first-page":"128928","DOI":"10.1016\/j.bmcl.2022.128928","volume":"74","author":"Caldwell","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"D5RA05472A\/cit90\/1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1505270","volume":"373","author":"Turner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit91\/1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(14)71159-3","volume":"16","author":"Finn","year":"2015","journal-title":"Lancet Oncol."},{"key":"D5RA05472A\/cit92\/1","author":"FDA","unstructured":"FDA ,  FDA approves inavolisib with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-inavolisib-palbociclib-and-fulvestrant-endocrine-resistant-pik3ca-mutated-hr-positive"},{"key":"D5RA05472A\/cit93\/1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmech.2019.03.064","volume":"172","author":"Poratti","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"D5RA05472A\/cit94\/1","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2017.73.7585","volume":"35","author":"Sledge Jr","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit95\/1","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","volume":"35","author":"Goetz","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit96\/1","author":"FDA","unstructured":"FDA ,  FDA expands early breast cancer indication for abemaciclib with endocrine therapy ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-expands-early-breast-cancer-indication-abemaciclib-endocrine-therapy"},{"key":"D5RA05472A\/cit97\/1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejmech.2019.06.005","volume":"178","author":"Shi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"D5RA05472A\/cit98\/1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12885-023-10996-y","volume":"23","author":"Armstrong","year":"2023","journal-title":"BMC Cancer"},{"key":"D5RA05472A\/cit99\/1","first-page":"136","volume-title":"Healx Candidate, SpringWorks Therapy Expand NF1 Treatment Options: Healx doses first patient in Phase II trial of HLX-1502 for neurofibromatosis type 1, while SpringWorks wins FDA approval for Gomekli, first drug designed to treat the disease in adults and children","volume":"7","author":"Philippidis","year":"2025","unstructured":"A.Philippidis ,  Healx Candidate, SpringWorks Therapy Expand NF1 Treatment Options: Healx doses first patient in Phase II trial of HLX-1502 for neurofibromatosis type 1, while SpringWorks wins FDA approval for Gomekli, first drug designed to treat the disease in adults and children ,  2025 ,  vol. 7 ,  pp. 136\u2013141"},{"key":"D5RA05472A\/cit100\/1","author":"FDA","unstructured":"FDA ,  FDA approves mirdametinib for adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-mirdametinib-adult-and-pediatric-patients-neurofibromatosis-type-1-who-have-symptomatic"},{"key":"D5RA05472A\/cit101\/1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","volume":"382","author":"Gross","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit102\/1","doi-asserted-by":"crossref","first-page":"116631","DOI":"10.1016\/j.ejmech.2024.116631","volume":"275","author":"Hashem","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"D5RA05472A\/cit103\/1","doi-asserted-by":"crossref","first-page":"115236","DOI":"10.1016\/j.ejmech.2023.115236","volume":"251","author":"Hao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"D5RA05472A\/cit104\/1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.71423\/aimed.20250806","volume":"26","author":"Zhang","year":"2025","journal-title":"AI Med"},{"key":"D5RA05472A\/cit105\/1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.chembiol.2019.05.005","volume":"26","author":"Hafner","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"D5RA05472A\/cit106\/1","doi-asserted-by":"publisher","DOI":"10.1039\/D5MD00494B","author":"Elgawish","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"16","key":"D5RA05472A\/cit107\/1","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1200\/JCO.2022.40.16_suppl.2587","volume":"40","author":"Andre","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit108\/1","author":"FDA","unstructured":"FDA ,  FDA expands endometrial cancer indication for dostarlimab-gxly with chemotherapy ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-expands-endometrial-cancer-indication-dostarlimab-gxly-chemotherapy"},{"key":"D5RA05472A\/cit109\/1","doi-asserted-by":"crossref","first-page":"102254","DOI":"10.1016\/j.esmoop.2024.102254","volume":"9","author":"Lakhani","year":"2024","journal-title":"ESMO Open"},{"key":"D5RA05472A\/cit110\/1","author":"FDA","unstructured":"FDA ,  FDA grants accelerated approval to retifanlimab-dlwr for metastatic or recurrent locally advanced Merkel cell carcinoma ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-retifanlimab-dlwr-metastatic-or-recurrent-locally-advanced-merkel"},{"key":"D5RA05472A\/cit111\/1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","volume":"369","author":"Wolchok","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit112\/1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit113\/1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"Tawbi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit114\/1","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/medicina58111572","volume":"58","author":"Alkholifi","year":"2022","journal-title":"Medicina"},{"key":"D5RA05472A\/cit115\/1","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3390\/molecules30132686","volume":"30","author":"Kciuk","year":"2025","journal-title":"Molecules"},{"key":"D5RA05472A\/cit116\/1","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","volume":"38","author":"Gupta","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit117\/1","doi-asserted-by":"crossref","first-page":"e0290872","DOI":"10.1371\/journal.pone.0290872","volume":"18","author":"Lin","year":"2023","journal-title":"PLoS One"},{"key":"D5RA05472A\/cit118\/1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2020.01.018","volume":"26","author":"Kurtzberg","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"D5RA05472A\/cit119\/1","author":"Mahat","year":"2025","journal-title":"JAMA"},{"key":"D5RA05472A\/cit120\/1","author":"FDA","unstructured":"FDA ,  FDA approves remestemcel-L-rknd for steroid-refractory acute graft versus\nhost disease in pediatric patients ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-remestemcel-l-rknd-steroid-refractory-acute-graft-versus-host-disease-pediatric"},{"key":"D5RA05472A\/cit121\/1","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcyt.2025.03.080","volume":"27","author":"Bako","year":"2025","journal-title":"Cytotherapy"},{"key":"D5RA05472A\/cit122\/1","first-page":"183","volume-title":"Extracellular Vesicles and Circulating Nucleic Acids","volume":"6","author":"Giebel","year":"2025","unstructured":"B.Giebel ,  Extracellular Vesicles and Circulating Nucleic Acids ,  2025 , vol.  6 ,  p. 183"},{"key":"D5RA05472A\/cit123\/1","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1021\/acs.jmedchem.4c02151","volume":"68","author":"Bi","year":"2025","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit124\/1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41416-024-02766-9","volume":"131","author":"Poumeaud","year":"2024","journal-title":"Br. J. Cancer"},{"key":"D5RA05472A\/cit125\/1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/COC.0000000000001135","volume":"47","author":"Bouziane","year":"2024","journal-title":"Am. J. Clin. Oncol."},{"key":"D5RA05472A\/cit126\/1","author":"FDA","unstructured":"FDA ,  FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HR-positive, HER2-low or HER2-ultralow breast cancer ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-hr-positive-her2-low-or-her2"},{"key":"D5RA05472A\/cit127\/1","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.3390\/ijms26136523","volume":"26","author":"Jang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"D5RA05472A\/cit128\/1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acs.bioconjchem.2c00177","volume":"33","author":"Matikonda","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"D5RA05472A\/cit129\/1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1535-7163.MCT-21-0206","volume":"20","author":"Okajima","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"D5RA05472A\/cit130\/1","first-page":"e20674","volume":"43","author":"Parekh","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit131\/1","author":"FDA","unstructured":"FDA ,  FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-datopotamab-deruxtecan-dlnk-unresectable-or-metastatic-hr-positive-her2-negative-breast"},{"key":"D5RA05472A\/cit132\/1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1158\/1078-0432.CCR-24-1948","volume":"31","author":"Meric-Bernstam","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"D5RA05472A\/cit133\/1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12032-024-02542-y","volume":"41","author":"Sawant","year":"2024","journal-title":"Med. Oncol."},{"key":"D5RA05472A\/cit134\/1","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s13346-024-01564-3","volume":"14","author":"Mer","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"D5RA05472A\/cit135\/1","author":"FDA","unstructured":"FDA ,  FDA grants accelerated approval to telisotuzumab vedotin-tllv for NSCLC with high c-Met protein overexpression ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-telisotuzumab-vedotin-tllv-nsclc-high-c-met-protein-overexpression"},{"key":"D5RA05472A\/cit136\/1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14737140.2023.2257885","volume":"23","author":"Schreiber","year":"2023","journal-title":"Expet Rev. Anticancer Ther."},{"key":"D5RA05472A\/cit137\/1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejps.2014.12.010","volume":"68","author":"G\u0142\u00f3wka","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"D5RA05472A\/cit138\/1","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s00432-021-03836-8","volume":"148","author":"O\u2018Hagan Henderson","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"D5RA05472A\/cit139\/1","author":"FDA","unstructured":"FDA ,  FDA approves treosulfan with fludarabine as a preparative regimen for alloHSCT in adult and pediatric patients with AML or MDS ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-treosulfan-fludarabine-preparative-regimen-allohsct-adult-and-pediatric-patients-aml-or"},{"key":"D5RA05472A\/cit140\/1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40262-018-0647-4","volume":"57","author":"Roma\u0144ski","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"D5RA05472A\/cit141\/1","first-page":"5470","volume":"60","author":"Westerhof","year":"2000","journal-title":"Cancer Res."},{"key":"D5RA05472A\/cit142\/1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1200\/JCO.2024.42.3_suppl.128","volume":"42","author":"Yaeger","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit143\/1","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa2308795","volume":"389","author":"Fakih","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit144\/1","author":"FDA","unstructured":"FDA ,  FDA approves sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-sotorasib-panitumumab-kras-g12c-mutated-colorectal-cancer"},{"key":"D5RA05472A\/cit145\/1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"D5RA05472A\/cit146\/1","doi-asserted-by":"crossref","first-page":"116771","DOI":"10.1016\/j.ejmech.2024.116771","volume":"277","author":"Pandey","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"D5RA05472A\/cit147\/1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/2159-8290.CD-23-1138","volume":"14","author":"Rubinson","year":"2024","journal-title":"Cancer Discov."},{"key":"D5RA05472A\/cit148\/1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13046-021-02225-w","volume":"41","author":"Kwan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"D5RA05472A\/cit149\/1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41591-024-03443-3","volume":"31","author":"Kopetz","year":"2025","journal-title":"Nat. Med."},{"issue":"9","key":"D5RA05472A\/cit150\/1","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/pharmaceutics13091478","volume":"13","author":"Aboubakar Nana","year":"2021","journal-title":"Pharmaceutics"},{"key":"D5RA05472A\/cit151\/1","author":"FDA","unstructured":"FDA ,  FDA grants accelerated approval to encorafenib with cetuximab and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-encorafenib-cetuximab-and-mfolfox6-metastatic-colorectal-cancer-braf"},{"key":"D5RA05472A\/cit152\/1","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","volume":"381","author":"Kopetz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit153\/1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/14756366.2016.1190715","volume":"31","author":"Gamal El-Din","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"D5RA05472A\/cit154\/1","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1200\/JCO.21.01210","volume":"39","author":"Byrd","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"D5RA05472A\/cit155\/1","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1200\/JCO-25-00690","volume":"43","author":"Wang","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit156\/1","author":"FDA","unstructured":"FDA ,  FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphoma ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-acalabrutinib-bendamustine-and-rituximab-previously-untreated-mantle-cell-lymphoma"},{"issue":"12","key":"D5RA05472A\/cit157\/1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1021\/acsmedchemlett.6b00480","volume":"7","author":"Silverman","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"D5RA05472A\/cit158\/1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1509981","volume":"374","author":"Byrd John","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit159\/1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-016-0250-9","volume":"9","author":"Wu","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"D5RA05472A\/cit160\/1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-19-1167","volume":"10","author":"Hallin","year":"2020","journal-title":"Cancer Discov."},{"key":"D5RA05472A\/cit161\/1","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","volume":"381","author":"Kopetz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"D5RA05472A\/cit162\/1","doi-asserted-by":"publisher","first-page":"101832","DOI":"10.1136\/ijgc-2024-005919","author":"Grisham","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"D5RA05472A\/cit163\/1","volume-title":"Targeted Therapy in Low-Grade Serous Ovarian Carcinoma: Characterization of MEK Inhibitor Response in Novel Patient-Derived Cell Lines","author":"Dawson","year":"2016","unstructured":"A.Dawson ,  Targeted Therapy in Low-Grade Serous Ovarian Carcinoma: Characterization of MEK Inhibitor Response in Novel Patient-Derived Cell Lines ,  University of British Columbia ,  2016"},{"key":"D5RA05472A\/cit164\/1","author":"FDA","unstructured":"FDA ,  FDA grants accelerated approval to the combination of avutometinib and defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-combination-avutometinib-and-defactinib-kras-mutated-recurrent-low"},{"key":"D5RA05472A\/cit165\/1","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1039\/D3MD00145H","volume":"14","author":"Ram","year":"2023","journal-title":"RSC Med. Chem."},{"key":"D5RA05472A\/cit166\/1","doi-asserted-by":"crossref","first-page":"20957","DOI":"10.1039\/D5RA01880C","volume":"15","author":"Zhu","year":"2025","journal-title":"RSC Adv."},{"key":"D5RA05472A\/cit167\/1","doi-asserted-by":"crossref","first-page":"113573","DOI":"10.1016\/j.ejmech.2021.113573","volume":"222","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"D5RA05472A\/cit168\/1","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1158\/1078-0432.CCR-24-0103","volume":"30","author":"Gelderblom","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"D5RA05472A\/cit169\/1","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1158\/1535-7163.MCT-21-0361","volume":"20","author":"Smith","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"D5RA05472A\/cit170\/1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s40265-025-02190-0","volume":"85","author":"Hoy","year":"2025","journal-title":"Drugs"},{"key":"D5RA05472A\/cit171\/1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/neuonc\/noac165","volume":"24","author":"de Blank","year":"2022","journal-title":"Neuro Oncol."},{"key":"D5RA05472A\/cit172\/1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ccell.2020.08.002","volume":"38","author":"Li","year":"2020","journal-title":"Cancer Cell"},{"key":"D5RA05472A\/cit173\/1","doi-asserted-by":"crossref","first-page":"102224","DOI":"10.1016\/j.ctrv.2021.102224","volume":"98","author":"An","year":"2021","journal-title":"Cancer Treat Rev."},{"key":"D5RA05472A\/cit174\/1","volume-title":"Divarasib Shows Activity in Patients With KRAS-Mutated Solid Tumors","author":"Primeau","year":"2023","unstructured":"A. S. B.Primeau ,  Divarasib Shows Activity in Patients With KRAS-Mutated Solid Tumors , Cancer Therapy Advisor,  2023"},{"key":"D5RA05472A\/cit175\/1","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1016\/j.cell.2024.08.017","volume":"187","author":"Morstein","year":"2024","journal-title":"Cell"},{"key":"D5RA05472A\/cit176\/1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21541248.2025.2505441","volume":"15","author":"Fernando","year":"2024","journal-title":"Small GTPases"},{"key":"D5RA05472A\/cit177\/1","doi-asserted-by":"crossref","first-page":"468214","DOI":"10.1200\/JCO.2024.42.36_suppl.468214","volume":"42","author":"Shi","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit178\/1","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acs.jmedchem.4c02939","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit179\/1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/2767-9764.CRC-25-0001","volume":"5","author":"Wang","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"D5RA05472A\/cit180\/1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41375-025-02515-8","volume":"39","author":"Bewersdorf","year":"2025","journal-title":"Leukemia"},{"key":"D5RA05472A\/cit181\/1","doi-asserted-by":"crossref","first-page":"39653","DOI":"10.1039\/D4RA05497K","volume":"14","author":"Hu","year":"2024","journal-title":"RSC Adv."},{"key":"D5RA05472A\/cit182\/1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nchembio.1810","volume":"11","author":"Chan-Penebre","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"D5RA05472A\/cit183\/1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41375-025-02515-8","volume":"39","author":"Bewersdorf","year":"2025","journal-title":"Leukemia"},{"key":"D5RA05472A\/cit184\/1","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1200\/JCO.2023.41.16_suppl.3094","volume":"41","author":"Drescher","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit185\/1","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1021\/acs.jmedchem.2c00047","volume":"65","author":"Xia","year":"2022","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit186\/1","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1158\/0008-5472.CAN-24-0398","volume":"84","author":"Keller","year":"2024","journal-title":"Cancer Res."},{"key":"D5RA05472A\/cit187\/1","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/ijc.25202","volume":"126","author":"Delage","year":"2010","journal-title":"Int. J. Cancer"},{"key":"D5RA05472A\/cit188\/1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00253-021-11728-7","volume":"106","author":"Schwarz","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"D5RA05472A\/cit189\/1","first-page":"4060","volume":"125","author":"Miraki-Moud","year":"2015","journal-title":"J. Am. Soc. Hematol."},{"key":"D5RA05472A\/cit190\/1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11864-025-01317-5","volume":"26","author":"Ayzman","year":"2025","journal-title":"Curr. Treat. Options Oncol."},{"key":"D5RA05472A\/cit191\/1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"key":"D5RA05472A\/cit192\/1","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.7150\/thno.96403","volume":"14","author":"Bidkar","year":"2024","journal-title":"Theranostics"},{"key":"D5RA05472A\/cit193\/1","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1021\/acsomega.4c10142","volume":"10","author":"Sch\u00e4fer","year":"2025","journal-title":"ACS Omega"},{"key":"D5RA05472A\/cit194\/1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2217\/imt.15.67","volume":"7","author":"Goodfellow","year":"2015","journal-title":"Immunotherapy"},{"key":"D5RA05472A\/cit195\/1","doi-asserted-by":"crossref","first-page":"e1433516","DOI":"10.1080\/2162402X.2018.1433516","volume":"7","author":"Patel","year":"2018","journal-title":"OncoImmunology"},{"key":"D5RA05472A\/cit196\/1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.bioconjchem.2c00592","volume":"34","author":"Irie","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"D5RA05472A\/cit197\/1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/17576180.2025.2481021","volume":"17","author":"Bhole","year":"2025","journal-title":"Bioanalysis"},{"key":"D5RA05472A\/cit198\/1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/med.21877","volume":"42","author":"He","year":"2022","journal-title":"Med. Res. Rev."},{"key":"D5RA05472A\/cit199\/1","doi-asserted-by":"crossref","first-page":"112436","DOI":"10.1016\/j.ejmech.2020.112436","volume":"200","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"D5RA05472A\/cit200\/1","doi-asserted-by":"crossref","first-page":"16901","DOI":"10.3390\/ijms242316901","volume":"24","author":"Maines","journal-title":"Int. J. Mol. Sci."},{"key":"D5RA05472A\/cit201\/1","author":"Tawati","year":"2018","unstructured":"S. M.Tawati ,  Design, synthesis and biological evaluation of sphingosine kinase inhibitors for the treatment of prostate cancer ,  2018 ,  https:\/\/stax.strath.ac.uk\/concern\/theses\/js956f85s"},{"key":"D5RA05472A\/cit202\/1","doi-asserted-by":"crossref","first-page":"9310","DOI":"10.1021\/jm401399c","volume":"56","author":"Baek","year":"2013","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit203\/1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/acsbiomedchemau.2c00017","volume":"2","author":"Pashikanti","year":"2022","journal-title":"ACS Bio Med Chem Au"},{"key":"D5RA05472A\/cit204\/1","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1200\/jco.2009.27.15_suppl.7021","volume":"27","author":"Garcia-Manero","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit205\/1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3390\/biom10050744","volume":"10","author":"Khan","year":"2020","journal-title":"Biomolecules"},{"key":"D5RA05472A\/cit206\/1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/13543784.2012.660249","volume":"21","author":"Liu","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"D5RA05472A\/cit207\/1","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1158\/1538-7445.AM2023-4074","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res."},{"key":"D5RA05472A\/cit208\/1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1158\/2767-9764.CRC-24-0170","volume":"5","author":"Ohlstrom","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"D5RA05472A\/cit209\/1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107512","volume":"190","author":"Hong","year":"2024","journal-title":"Lung Cancer"},{"key":"D5RA05472A\/cit210\/1","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4155\/fmc-2018-0200","volume":"10","author":"Zhang","year":"2018","journal-title":"Future Med. Chem."},{"key":"D5RA05472A\/cit211\/1","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-17-1192","volume":"23","author":"Engstrom","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"D5RA05472A\/cit212\/1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4939-2553-7_10","volume-title":"Textbook of Personalized Medicine","author":"Jain","year":"2015","unstructured":"K. K.Jain , in  Textbook of Personalized Medicine , ed.  K. K. Jain ,  Springer New York ,  New York, NY ,  2015 ,  pp. 199\u2013381 ,  10.1007\/978-1-4939-2553-7_10"},{"key":"D5RA05472A\/cit213\/1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(12)60485-1","volume":"379","author":"Castaigne","year":"2012","journal-title":"Lancet"},{"key":"D5RA05472A\/cit214\/1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1039\/9781839165153-00213","volume-title":"Chemical Linkers in Antibody\u2013Drug Conjugates (ADCs)","author":"Savoy","year":"2021","unstructured":"E. A.Savoy ,  F. P.Olatunji ,  H.Yoon ,  N.Mesbahi ,  J. R.Knight  and  C. E.Berkman ,  Acid-labile linkers ,  Chemical Linkers in Antibody\u2013Drug Conjugates (ADCs) ,  2021 ,  pp. 213\u2013231 ,  10.1039\/9781839165153-00213"},{"key":"D5RA05472A\/cit215\/1","first-page":"1490","volume":"7","author":"Bross","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"D5RA05472A\/cit216\/1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1158\/1078-0432.CCR-20-2149","volume":"27","author":"Han","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"D5RA05472A\/cit217\/1","doi-asserted-by":"crossref","first-page":"e786","DOI":"10.1016\/S2352-3026(23)00278-8","volume":"10","author":"Rodriguez-Otero","year":"2023","journal-title":"Lancet Haematol."},{"key":"D5RA05472A\/cit218\/1","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1158\/1078-0432.CCR-22-0618","volume":"28","author":"Baines","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"D5RA05472A\/cit219\/1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bjh.17235","volume":"193","author":"Demel","year":"2021","journal-title":"Br. J. Haematol."},{"key":"D5RA05472A\/cit220\/1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.annonc.2025.01.011","volume":"36","author":"Powles","year":"2025","journal-title":"Ann. Oncol."},{"key":"D5RA05472A\/cit221\/1","doi-asserted-by":"crossref","first-page":"1323366","DOI":"10.3389\/fonc.2024.1323366","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"key":"D5RA05472A\/cit222\/1","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.7150\/thno.98178","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"D5RA05472A\/cit223\/1","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1182\/blood.V130.Suppl_1.847.847","volume":"130","author":"Horwitz","year":"2017","journal-title":"Blood"},{"key":"D5RA05472A\/cit224\/1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14712598.2020.1776255","volume":"21","author":"Hartley","year":"2021","journal-title":"Expet Opin. Biol. Ther."},{"key":"D5RA05472A\/cit225\/1","doi-asserted-by":"crossref","first-page":"2381891","DOI":"10.1080\/19420862.2024.2381891","volume":"16","author":"Murer","year":"2024","journal-title":"mAbs"},{"key":"D5RA05472A\/cit226\/1","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1021\/acs.jmedchem.4c00227","volume":"67","author":"Thomson","year":"2024","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit227\/1","volume-title":"Drugs\/Approved Drugs","author":"FDA US","year":"2021","unstructured":"FDA US ,  FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations , in  Drugs\/Approved Drugs ,  US Food & Drug Administration ,  Silver Spring, MD ,  2021"},{"key":"D5RA05472A\/cit228\/1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00044-022-02952-5","volume":"31","author":"Wang","year":"2022","journal-title":"Med. Chem. Res."},{"key":"D5RA05472A\/cit229\/1","doi-asserted-by":"crossref","first-page":"129084","DOI":"10.1016\/j.bmcl.2022.129084","volume":"80","author":"Huang","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"D5RA05472A\/cit230\/1","author":"FDA","unstructured":"FDA ,  WITHDRAWN: FDA grants accelerated approval to infigratinib for metastatic cholangiocarcinoma ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/withdrawn-fda-grants-accelerated-approval-infigratinib-metastatic-cholangiocarcinoma"},{"key":"D5RA05472A\/cit231\/1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1200\/JCO.2024.42.3_suppl.516","volume":"42","author":"Abou-Alfa","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit232\/1","first-page":"101204","volume":"4","author":"Subbiah","year":"2023","journal-title":"Medicine"},{"key":"D5RA05472A\/cit233\/1","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.2174\/0929867329666220822123552","volume":"30","author":"Choi","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"D5RA05472A\/cit234\/1","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1021\/jm2006222","volume":"54","author":"Guagnano","year":"2011","journal-title":"J. Med. Chem."},{"key":"D5RA05472A\/cit235\/1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.21147\/j.issn.1000-9604.2022.04.09","volume":"34","author":"Zou","year":"2022","journal-title":"Chin. J. Cancer Res."},{"key":"D5RA05472A\/cit236\/1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/cmdc.201600148","volume":"11","author":"Scott","year":"2016","journal-title":"ChemMedChem"},{"key":"D5RA05472A\/cit237\/1","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.2147\/DDDT.S142406","author":"Krause","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"D5RA05472A\/cit238\/1","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2352-3026(21)00381-1","volume":"9","author":"Schjesvold","year":"2022","journal-title":"Lancet Haematol."},{"key":"D5RA05472A\/cit239\/1","doi-asserted-by":"crossref","first-page":"114494","DOI":"10.1016\/j.ejmech.2022.114494","volume":"238","author":"Pahwa","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"D5RA05472A\/cit240\/1","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1158\/1078-0432.CCR-12-3752","volume":"19","author":"Chauhan","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"D5RA05472A\/cit241\/1","author":"FDA","unstructured":"FDA ,  Withdrawn | Cancer Accelerated Approvals ,  https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/withdrawn-cancer-accelerated-approvals"},{"key":"D5RA05472A\/cit242\/1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1541-7786.MCR-19-1203","volume":"18","author":"Becker","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"D5RA05472A\/cit243\/1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00280-012-2042-4","volume":"71","author":"Silverman","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"D5RA05472A\/cit244\/1","volume-title":"Regular and Young Investigator Award Abstracts","volume":"9","author":"Hellmann","year":"2021","unstructured":"M.Hellmann ,  B.Cho ,  R.Juergens ,  Y.Cheng ,  G.de Castro ,  M.Erman ,  J.Bauman ,  T.Takahashi ,  P.Schwarzenberger  and  P.Zhang ,  Regular and Young Investigator Award Abstracts ,  2021 , vol.  9 ,  pp. A488"},{"key":"D5RA05472A\/cit245\/1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/mab.2021.0006","volume":"40","author":"Takei","year":"2021","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"D5RA05472A\/cit246\/1","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2023-182119","volume":"142","author":"Lavie","year":"2023","journal-title":"Blood"},{"key":"D5RA05472A\/cit247\/1","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1038\/s41598-024-61477-6","volume":"14","author":"Dai","year":"2024","journal-title":"Sci. Rep."},{"key":"D5RA05472A\/cit248\/1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/cancers17060958","volume":"17","author":"Buyukgolcigezli","year":"2025","journal-title":"Cancers"},{"key":"D5RA05472A\/cit249\/1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"key":"D5RA05472A\/cit250\/1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"D5RA05472A\/cit251\/1","first-page":"429","volume-title":"Spatially Variable Genes in Cancer: Development, Progression, and Treatment Response","author":"Selvakumar","year":"2025","unstructured":"P.Selvakumar ,  M.Prabakaran  and  S.Bhattacharya , in  Spatially Variable Genes in Cancer: Development, Progression, and Treatment Response ,  IGI Global Scientific Publishing ,  2025 ,  pp. 429\u2013446"},{"key":"D5RA05472A\/cit252\/1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14712598.2024.2305266","volume":"24","author":"Hingorani","year":"2024","journal-title":"Expet Opin. Biol. Ther."},{"issue":"16","key":"D5RA05472A\/cit253\/1","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.2022.40.16_suppl.3032","volume":"40","author":"Wynn","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"D5RA05472A\/cit254\/1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/ph14030247","volume":"14","author":"Conilh","year":"2021","journal-title":"Pharmaceuticals"},{"key":"D5RA05472A\/cit255\/1","doi-asserted-by":"crossref","first-page":"104115","DOI":"10.1016\/j.drudis.2024.104115","volume":"29","author":"Shivani","year":"2024","journal-title":"Drug discovery today"},{"key":"D5RA05472A\/cit256\/1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13321-023-00766-0","volume":"15","author":"Hu","year":"2023","journal-title":"J. Cheminf."},{"key":"D5RA05472A\/cit257\/1","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/17460441.2024.2409674","volume":"19","author":"Mishra","year":"2024","journal-title":"Expet Opin. Drug Discov."},{"key":"D5RA05472A\/cit258\/1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.9734\/jcti\/2025\/v15i2294","volume":"15","author":"Okafor","year":"2025","journal-title":"J. Cancer Tumor Int."},{"key":"D5RA05472A\/cit259\/1","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"D5RA05472A\/cit260\/1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2533\/chimia.2022.341","volume":"76","author":"Cecchini","year":"2022","journal-title":"Chimia"},{"key":"D5RA05472A\/cit261\/1","doi-asserted-by":"crossref","first-page":"e202507702","DOI":"10.1002\/anie.202507702","volume":"64","author":"Zhang","year":"2025","journal-title":"Angew. Chem."},{"key":"D5RA05472A\/cit263\/1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/acsmedchemlett.9b00597","volume":"11","author":"Gao","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"D5RA05472A\/cit264\/1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["RSC Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.rsc.org\/en\/content\/articlepdf\/2025\/RA\/D5RA05472A","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:46:19Z","timestamp":1782881179000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.rsc.org\/ra\/article\/15\/43\/36441-36471\/908006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":264,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025,9,26]]}},"URL":"https:\/\/doi.org\/10.1039\/d5ra05472a","relation":{"has-review":[{"id-type":"doi","id":"10.1039\/D5RA05472A\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA05472A\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA05472A\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA05472A\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA05472A\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA05472A\/v1\/decision1","asserted-by":"object"}]},"ISSN":["2046-2069"],"issn-type":[{"value":"2046-2069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}